SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: John Lacelle who wrote (3268)11/24/1999 11:35:00 AM
From: rl  Respond to of 3369
 
Thanks for that info. Could you share the web address. SDS and SeroStrip have been in front of WHO for over five years. The determining factor in successful sales through WHO and listing in their catalogue is price. The third world is totally cost conscious and will sacrifice some sensitivity and specificity for lower cost. This listing for SeroStrip is not new and probably won't mean one sale for SDS even if they could produce it. Heck, maybe there's a market in Gambia for cheap SALV stock. The piggies will sell anything to make a buck.



To: John Lacelle who wrote (3268)11/30/1999 12:34:00 AM
From: s martin  Read Replies (1) | Respond to of 3369
 
The CDC liked the SDS HIV test and was in fact purchasing the kits for use in countries where refrigeration and labs were nil. Anyone ever talk to Dr. Seymour ? I wonder what his thoughts on this would be. He was going to be behind the push to get FDA approval.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News